Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Bacil Pharma Share Price

Bacil Pharma Ltd.

₹52.60

2.50(4.99%)

Trade Now

2nd Apr 2026 | 3:22 PM

NSE :

Open Free Demat Account

Bacil Pharma Performance

Price Movement

N/A

₹48.60

₹52.60

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹52.60

Low₹48.60

Open at₹52.50

Prev Close₹50.10

Volumes10.07 K

Avg Price₹52.34

Lower Circuit₹47.60

Upper Circuit₹52.60

Historical Performance

3M High₹52.60

3M Low₹35.06

1 Yr High₹52.60

1 Yr Low₹26.69

3 Yr High₹62.56

3 Yr Low₹4.68

5 Yr High₹62.56

5 Yr Low₹3.27

Bacil Pharma Fundamentals

Market Cap

Below industry Median

75.50 Cr.

PE Ratio (TTM)

High in industry

102.40

Dividend Yield

Net Profit TTM

111.4% incr over last year

0.74

Net Profit Growth

111.4% incr over last year

0.74

PEG Ratio

Above industry Median

0.90

ROE

132.6% incr over last year

1.58

Operating Revenue TTM

Operating Revenue Growth

Book Value

Above industry Median

2.80

MFI

MFI is mid-range

42.98

RSI

RSI is mid-range

63.02

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

2.80

Bacil Pharma Financials

Data not available for chart

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	0	0	0	0
Operating Expense	0.03	0.04	0.11	0.07	0.06
Operating Profit	-0.03	-0.04	-0.11	-0.07	-0.06
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0.22	0	0
Net Profit	0.04	0.01	0.67	0.02	-0.06

Bacil Pharma Technicals

Bacil Pharma Ltd. EMA & SMA

₹52.60

2.50 (4.99%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹49.9

Day EMA10 ₹49.1

Day EMA12 ₹49

Day EMA20 ₹48.4

Day EMA26 ₹47.8

Day EMA50 ₹45.9

Day EMA100 ₹43.5

Day EMA200 ₹41

Bacil Pharma Support and Resistance

Resistance

First Resistance₹53.93

Second Resistance₹55.27

Third Resistance₹57.93

Support

First Support₹49.93

Second Support₹47.27

Third Support₹45.93

Technical Indicators

Day RSI63.02

Day MFI42.98

Day ADX25.91

Day Commodity Channel Index199.40

William-

Day MACD1.13

Day MACD Signal Line1.12

Day ATR3.87

Day ROC12526.11

Day ROC218.79

Bacil Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	20.7	10.6	0.2	0.2	0.1	0.1
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	79.3	89.4	99.8	99.8	99.9	99.9

Bacil Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	46.26 K	51.38 K	90.04%
Week	44.99 K	47.34 K	95.02%
1 Month	20.04 K	22.4 K	89.47%
6 Month	17.07 K	19.28 K	88.53%

Bacil Pharma SWOT Analysis

Strengths28

Weakness3

Opportunity0

Threats0

Positive Breakout First Resistance ( LTP > R1)

Price crossing above SMA20 today, and greater than SMA5

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

New 52 Week High

Stocks Outperforming their Industry Price Change in the Quarter

Bacil Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Bacil Pharma Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹201.95	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	-1.49%	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	56.00	-95.60	-1.40	11.90	76.40	27.40
1 Year Return		735.56	479	-29.73		-14.23
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on BACPHAR

What is the Market Capitalization of Bacil Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for Bacil Pharma Ltd. is approximately ₹ 75.5 Cr.

What are the PE and PB ratios for Bacil Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bacil Pharma Ltd. is 102.4, and the Price-to-Book (PB) ratio is 2.8.

What is the 52-Week High and Low for Bacil Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Bacil Pharma Ltd. shares was ₹ 52.6, and the lowest price was ₹ 26.69.

Who are the major shareholders of Bacil Pharma Ltd.?

Significant shareholdings in Bacil Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bacil Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bacil Pharma Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy